<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00750776</url>
  </required_header>
  <id_info>
    <org_study_id>NIS-NDK-DUM-2002/1</org_study_id>
    <nct_id>NCT00750776</nct_id>
  </id_info>
  <brief_title>KvaliMed - a Quality Project With Focus on Patients in Antipsychotic Treatment</brief_title>
  <acronym>KvaliMed</acronym>
  <official_title>KvaliMed - a Quality Project With Focus on Patients in Antipsychotic Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Psychiatric Centre Rigshospitalet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Psychiatric Centre Rigshospitalet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rating and registration in KMS database of all patients in anti-psychotic treatment with 8
      selected items from PANSS, GAF, 21 selected items from UKU, 3 selected items from TSQM. and
      measurement of compliance. Frequency of use of rating scales per participating health care
      professional.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Due to lack of financial support
  </why_stopped>
  <start_date>August 2003</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>GAF score &gt;= 30 or have an improvement on &gt;= 5 points at the GAF scale</measure>
    <time_frame>All measures are rated every Â½ year at least.GAF: At least 85 % of the rated patients must have a score &gt;= 30 or have an improvement on &gt;= 5 points at the GAF scale</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>PANSS: Share af patients that have a score &gt;= 3 on each an every of the following items P1, P2, P3, N1, N4, N6, G5, G9</measure>
    <time_frame>PANSS: At least 70% of the patients have a score &lt;= 3 on each an every of the following items P1, P2, P3, N1, N4, N6, G5, G9</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>UKU: Share of patients that have a score &lt;=1 on the selected 21 items from the UKU scale</measure>
    <time_frame>UKU: At least 75 % of the patients have a score on &lt;=1 on the selected items UKU scale.At least 30 % of the patients are examined for metabolic syndrom.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance: Share of patients have according to the specialists evaluation have taken their antipsychotic medicine according to prescription</measure>
    <time_frame>Compliance: At least 75% of the patients have according to the specialists evaluation taken their antipsychotic medicine according to prescription</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction:Share of patients that scores in one of the to best categories i all selected 3 items in the TSQM scale.</measure>
    <time_frame>Patient satisfaction:At least 65 % of the patients scores in one of the to best kategories in all the selected 3 items in the TSQM scale.</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">212</enrollment>
  <condition>Antipsychotic Treatment</condition>
  <condition>Quality Assurance</condition>
  <condition>Medical Treatment</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients that are treatet with antipsycotic medicine - by a specialist in psychiatry - the
        patients can stay at the hospital or receive outpatient treatment
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients where a physician has decided to treat the patient with antipsychotics.

          -  All patients that are treated within the Danish health care system

        Exclusion Criteria:

          -  Patients that are treated in accordance with &quot;Law concerning freedom deprivation and
             other compulsion in psychiatry

          -  Patients that are in judicial measure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Soren Blikenberg</last_name>
    <role>Principal Investigator</role>
    <affiliation>Research Centre for Psychiatry Vordingborg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Maagensen</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children Psychiatry Holbaek</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Karin Byrsting</last_name>
    <role>Principal Investigator</role>
    <affiliation>Odense University Hospital Odense C Psychiatric Hospital Slagelse</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marianne Jacoby</last_name>
    <role>Principal Investigator</role>
    <affiliation>Outpatient TreatmentCopenhagen K</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter Christoffersen</last_name>
    <role>Principal Investigator</role>
    <affiliation>Psychiatric Hospital Slagelse</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Slagelse</city>
        <state>Dianalund</state>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Bjerringbro</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Brorup</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Esbjerg</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ResearcH Site</name>
      <address>
        <city>Holbaek</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Hviding</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Kobenhavn</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Naestved</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Thyholm</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Varde</city>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>April 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 10, 2008</study_first_submitted>
  <study_first_submitted_qc>September 10, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 11, 2008</study_first_posted>
  <last_update_submitted>April 14, 2013</last_update_submitted>
  <last_update_submitted_qc>April 14, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 16, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Psychiatric Centre Rigshospitalet</investigator_affiliation>
    <investigator_full_name>Anders Fink-Jensen, MD, DMSci</investigator_full_name>
    <investigator_title>Professor, senior consultant, DMSci</investigator_title>
  </responsible_party>
  <keyword>Quality assurance</keyword>
  <keyword>medical treatment</keyword>
  <keyword>Patient satisfaction</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antipsychotic Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

